FDA — authorised 27 March 2020
- Application: NDA212860
- Marketing authorisation holder: ROCKWELL MEDICAL INC
- Local brand name: TRIFERIC AVNU
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 Triferic AVNU in United States
FDA authorised Triferic AVNU on 27 March 2020
Marketing authorisation
Frequently asked questions
Is Triferic AVNU approved in United States?
Yes. FDA authorised it on 27 March 2020.
Who is the marketing authorisation holder for Triferic AVNU in United States?
ROCKWELL MEDICAL INC holds the US marketing authorisation.